approval
saveTECENTRIQ (ATEZOLIZUMAB) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionArcus Biosciences Inc — atezolizumab (Phase II Trial Completion)Apr 30, 2026 · 161d ago
- phase 0 trial completionDana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)Apr 29, 2026 · 162d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalNov 17, 2025 · 325d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025 · 371d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalAug 18, 2025 · 416d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalApr 22, 2024 · 899d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1245d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1245d ago
same company · ±60 days · 6
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalApr 30, 2021
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalMar 4, 2021
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalMar 4, 2021
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalFeb 17, 2021
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalFeb 17, 2021
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalFeb 17, 2021
🐶 often sniffed alongside
top 8- drugTECENTRIQ178 co-mentions · 46 sources
- tagApproval176 co-mentions · 44 sources
- companyGenentech Inc88 co-mentions · 44 sources
- drugTECENTRIQ HYBREZA20 co-mentions · 5 sources
- drug(atezolizumab + hyaluronidase (human recombinant))10 co-mentions · 5 sources
- tagOncology5 co-mentions · 2 sources
- companyDana-Farber Cancer Institute Inc1 co-mentions · 1 sources
- tagHepatology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that